acyclovir
Generic: acyclovir
Labeler: chartwell rx, llcDrug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
chartwell rx, llc
Dosage Form
SUSPENSION
Routes
Active Ingredients
acyclovir 200 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
62135-803
Product ID
62135-803_463b5fcf-cfc0-be52-e063-6394a90aa459
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA212718
Listing Expiration
2026-12-31
Marketing Start
2020-04-23
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
62135803
Hyphenated Format
62135-803
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA212718 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/5mL
Packaging
- 2 TRAY in 1 BOX (62135-803-23) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-803-20)
- 2 TRAY in 1 BOX (62135-803-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (62135-803-05)
- 473 mL in 1 BOTTLE (62135-803-47)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "463b5fcf-cfc0-be52-e063-6394a90aa459", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0362135803476"], "unii": ["X4HES1O11F"], "rxcui": ["307730"], "spl_set_id": ["7d2a75a5-233f-46dd-9cb0-3918ea53e554"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 TRAY in 1 BOX (62135-803-23) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (62135-803-20)", "package_ndc": "62135-803-23", "marketing_start_date": "20250320"}, {"sample": false, "description": "2 TRAY in 1 BOX (62135-803-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (62135-803-05)", "package_ndc": "62135-803-24", "marketing_start_date": "20250320"}, {"sample": false, "description": "473 mL in 1 BOTTLE (62135-803-47)", "package_ndc": "62135-803-47", "marketing_start_date": "20231130"}], "brand_name": "Acyclovir", "product_id": "62135-803_463b5fcf-cfc0-be52-e063-6394a90aa459", "dosage_form": "SUSPENSION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "62135-803", "generic_name": "Acyclovir", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/5mL"}], "application_number": "ANDA212718", "marketing_category": "ANDA", "marketing_start_date": "20200423", "listing_expiration_date": "20261231"}